Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Non Operating Investment Income (2010 - 2022)

Updated

Lexicon Pharmaceuticals (LXRX) recorded Non Operating Investment Income of -$27,000 in Q1 2022.

Analysis

Lexicon Pharmaceuticals (LXRX) Non Operating Investment Income (2010 - 2022) Analysis & Trends

For FY2010, Lexicon Pharmaceuticals reported Non Operating Investment Income of $141,000, down 88.0% from FY2009.

  • Across earlier years, Non Operating Investment Income came in at $1.17 million in FY2009.
  • The Q1 2022 figure is the highest quarterly Non Operating Investment Income since Q2 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -27,000.00
Jun 30, 2010 53,000.00
API Access

Lexicon Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LXRX&period=max&api_key=YOUR_API_KEY